Working… Menu

ACE-536 Extension Study - Beta Thalassemia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02268409
Recruitment Status : Completed
First Posted : October 20, 2014
Last Update Posted : May 19, 2021
Information provided by (Responsible Party):
Acceleron Pharma Inc.